National and Kapodistrian University of Athens
Μελέτη μοριακών μονοπατιών καρκινογένεσης σε καρκινώματα μαστού, με στόχο την ανάδειξη βιολογικών δεικτών για πρόγνωση και θεραπεία
Abstract
dc:descriptionBreast cancer is a a clinically and morphologically heterogeneous disease, the molecular basis of which has not been fully elucidated. Breast cancer research focuses on epigenetic modifications and signal transduction pathway molecules. In the present thesis, we studied DNA methylation of the promoters of selected genes and key-genesof PI3K/AKT pathway. We observed a berrant methylation of DCR1, DAPK1 and RASSF1A by MSP analysis and detected methylated loci in APC, MGMT, GSTP1 and PTEN promoters by MS-HRM in 49 breast cancer specimens. The results obtained by MS-HRMregarding the MGMT gene were validated by bisulfite pyrosequencing. An association of MGMT promoter methylation with age and tumour grade was recorded. Moreover, a correlation with advanced T-category was found for GSTP1, RASSF1 and DAPK1 promoter methylation. Finally, concurrent methylation of several genes showed a marginal statistical relationship with N-category reflecting the necessity for simultaneous detection of methylation in more than one gene in order to increase the clinical usefulness of methylation analyses for breast tumouri genesis. Further examination of genes displaying high methylation levels in larger cohorts could provide insight for new biomarkers for the early detection and/or disease monitoring, possibly influencing therapeutic decisions. Moreover, in the study of PI3K/AKT signaling pathway, we detected alterations at genetic level in 28% of breast carcinomas concerning PIK3CA(detection of a new mutation in breast cancer but also an extremely rare), in 4% ofAKT1 and 2.7% of PTEN, at epigenetic (methylation of PTEN) and transcriptional (statistically significantly increased expression of AKT2) level associated with clinicopathological features, revealing a very important role of this pathway in breast carcinogenesis. Our findings along with these of previous studies underlie the importance of PI3K/AKT pathway as a potential diagnostic marker of disease progression and as a potential therapeutic target. PI3K/AKT alterations in all aforementioned levels were detected mainly in breast carcinomas with positive expression of hormone receptors and HER2 contributing to elucidate the correlation of patient’s response to targeted therapies.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tserga, Aggeliki
- Τσέργα, Αγγελική
Subjects
dc:subject × 14- Καρκίνος μαστού
- Βιολογικός δείκτης
- Γονιδιακή μεθυλίωση
- Μοριακά μονοπάτια
- Breast cancer
- Biomarkers
- DNA methylation
- Molecular pathways
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62589